Early Allograft Dysfunction and Complications in DCD Liver Transplantation: Expert Consensus Statements From the International Liver Transplantation Society.
organ transplantation; liver transplantation; NHBD; cancer; complication; DCD
Abstract :
[en] Livers for transplantation from donation after circulatory death donors are relatively more prone to early and ongoing alterations in graft function that might ultimately lead to graft loss and even patient death. In consideration of this fact, this working group of the International Liver Transplantation Society has performed a critical evaluation of the medical literature to create a set of statements regarding the assessment of early allograft function/dysfunction and complications arising in the setting of donation after circulatory death liver transplantation.
Disciplines :
Gastroenterology & hepatology Surgery
Author, co-author :
Quintini, Cristiano
Muiesan, Paolo
Detry, Olivier ; Université de Liège - ULiège > Département des sciences cliniques > Pathologie chirurgicale abdominale et endocrinienne
Gastaca, Mikel
de Jonge, Jeroen
Clavien, Pierre-Alain
Del Prete, Luca
Fondevila, Constantino
Language :
English
Title :
Early Allograft Dysfunction and Complications in DCD Liver Transplantation: Expert Consensus Statements From the International Liver Transplantation Society.
Publication date :
August 2021
Journal title :
Transplantation
ISSN :
0041-1337
eISSN :
1534-6080
Publisher :
Lippincott Williams & Wilkins, United States - Maryland
Muller X, Marcon F, Sapisochin G,. Defining benchmarks in liver transplantation: a multicenter outcome analysis determining best achievable results. Ann Surg. 2018; 267: 419-425.
Lee DD, Singh A, Burns JM,. Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival. Liver Transpl. 2014; 20: 1447-1453.
Bohorquez H, Seal JB, Cohen AJ,. Safety and outcomes in 100 consecutive donation after circulatory death liver transplants using a protocol that includes thrombolytic therapy. Am J Transplant. 2017; 17: 2155-2164.
Croome KP, Mathur AK, Lee DD,. Outcomes of donation after circulatory death liver grafts from donors 50 years or older: a multicenter analysis. Transplantation. 2018; 102: 1108-1114.
Atkins D, Eccles M, Flottorp S, GRADE Working Group. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res. 2004; 4: 38.
Deschênes M, Belle SH, Krom RA,. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation. 1998; 66: 302-310.
Nanashima A, Pillay P, Verran DJ,. Analysis of initial poor graft function after orthotopic liver transplantation: experience of an australian single liver transplantation center. Transplant Proc. 2002; 34: 1231-1235.
Ben-Ari Z, Weiss-Schmilovitz H, Sulkes J,. Serum cholestasis markers as predictors of early outcome after liver transplantation. Clin Transplant. 2004; 18: 130-136.
Olthoff KM, Kulik L, Samstein B,. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010; 16: 943-949.
Pareja E, Cortes M, Hervás D,. A score model for the continuous grading of early allograft dysfunction severity. Liver Transpl. 2015; 21: 38-46.
Jochmans I, Fieuws S, Monbaliu D,. "Model for Early Allograft Function" outperforms "Early Allograft Dysfunction" as a predictor of transplant survival. Transplantation. 2017; 101: e258-e264.
Yunhua T, Weiqiang J, Maogen C,. The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation. J Clin Monit Comput. 2018; 32: 471-479.
Agopian VG, Harlander-Locke MP, Markovic D,. Evaluation of early allograft function using the liver graft assessment following transplantation risk score model. JAMA Surg. 2018; 153: 436-444.
Diaz-Nieto R, Lykoudis P, Robertson F,. A simple scoring model for predicting early graft failure and postoperative mortality after liver transplantation. Ann Hepatol. 2019; 18: 902-912.
Avolio AW, Franco A, Schlegel A,. Development and validation of a comprehensive model to estimate early allograft failure among patients requiring early liver retransplant. JAMA Surg. 2020; 155: e204095.
Agopian VG, Markovic D, Klintmalm GB,. Multicenter validation of the liver graft assessment following transplantation (L-GrAFT) score for assessment of early allograft dysfunction. J Hepatol. 2021; 74: 881-892.
Martins PN, Rizzari MD, Ghinolfi D, ILTS Special Interest Group "DCD, Preservation and Machine Perfusion". Design, analysis, and pitfalls of clinical trials using ex situ liver machine perfusion: the International Liver Transplantation Society Consensus Guidelines. Transplantation. 2021; 105: 796-815.
Nasralla D, Coussios CC, Mergental H, Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018; 557: 50-56.
Croome KP, Wall W, Quan D,. Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts. Hepatobiliary Pancreat Dis Int. 2012; 11: 372-376.
Mathur AK, Heimbach J, Steffick DE,. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant. 2010; 10: 2512-2519.
Bellingham JM, Santhanakrishnan C, Neidlinger N,. Donation after cardiac death: a 29-year experience. Surgery. 2011; 150: 692-702.
Foley DP, Fernandez LA, Leverson G,. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg. 2011; 253: 817-825.
Jay C, Ladner D, Wang E,. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant-an analysis of the national registry. J Hepatol. 2011; 55: 808-813.
Taner CB, Bulatao IG, Willingham DL,. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl. 2012; 18: 100-111.
Vanatta JM, Dean AG, Hathaway DK,. Liver transplant using donors after cardiac death: a single-center approach providing outcomes comparable to donation after brain death. Exp Clin Transplant. 2013; 11: 154-163.
Doyle MB, Collins K, Vachharajani N,. Outcomes using grafts from donors after cardiac death. J Am Coll Surg. 2015; 221: 142-152.
Firl DJ, Hashimoto K, O'Rourke C,. Impact of donor age in liver transplantation from donation after circulatory death donors: a decade of experience at Cleveland clinic. Liver Transpl. 2015; 21: 1494-1503.
Croome KP, Lee DD, Keaveny AP,. Improving national results in liver transplantation using grafts from donation after cardiac death donors. Transplantation. 2016; 100: 2640-2647.
Scalea JR, Redfield RR, Foley DP,. Liver transplant outcomes using ideal donation after circulatory death livers are superior to using older donation after brain death donor livers. Liver Transpl. 2016; 22: 1197-1204.
Croome KP, Lee DD, Perry DK,. Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity-matched cohort. Liver Transpl. 2017; 23: 342-351.
Goldberg DS, Karp SJ, McCauley ME,. Interpreting outcomes in DCDD liver transplantation: first report of the multicenter IDOL Consortium. Transplantation. 2017; 101: 1067-1073.
Kollmann D, Sapisochin G, Goldaracena N,. Expanding the donor pool: donation after circulatory death and living liver donation do not compromise the results of liver transplantation. Liver Transpl. 2018; 24: 779-789.
Dubbeld J, Hoekstra H, Farid W,. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg. 2010; 97: 744-753.
DeOliveira ML, Jassem W, Valente R,. Biliary complications after liver transplantation using grafts from donors after cardiac death: results from a matched control study in a single large volume center. Ann Surg. 2011; 254: 716-722.
Mallik M, Callaghan CJ, Hope M,. Comparison of liver transplantation outcomes from adult split liver and circulatory death donors. Br J Surg. 2012; 99: 839-847.
Meurisse N, Vanden Bussche S, Jochmans I,. Outcomes of liver transplantations using donations after circulatory death: a single-center experience. Transplant Proc. 2012; 44: 2868-2873.
Callaghan CJ, Charman SC, Muiesan P, UK Liver Transplant Audit. Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study. BMJ Open. 2013; 3: e003287.
Detry O, Deroover A, Meurisse N,. Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol programme. Br J Surg. 2014; 101: 784-792.
O'Neill S, Roebuck A, Khoo E,. A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation. Transpl Int. 2014; 27: 1159-1174.
Blok JJ, Detry O, Putter H, Eurotransplant Liver Intestine Advisory Committee. Longterm results of liver transplantation from donation after circulatory death. Liver Transpl. 2016; 22: 1107-1114.
Laing RW, Scalera I, Isaac J,. Liver transplantation using grafts from donors after circulatory death: a propensity score-matched Study from a single center. Am J Transplant. 2016; 16: 1795-1804.
Kalisvaart M, de Haan JE, Polak WG,. Comparison of postoperative outcomes between donation after circulatory death and donation after brain death liver transplantation using the comprehensive complication index. Ann Surg. 2017; 266: 772-778.
Schlegel A, Scalera I, Perera MTPR,. Impact of donor age in donation after circulatory death liver transplantation: is the cutoff "60" still of relevance? Liver Transpl. 2018; 24: 352-362.
Gilbo N, Jochmans I, Jacobs-Tulleneers-Thevissen D,. Survival of patients with liver transplants donated after euthanasia, circulatory death, or brain death at a single center in Belgium. JAMA. 2019; 322: 78-80.
Taylor R, Allen E, Richards JA, Liver Advisory Group to NHS Blood and Transplant. Survival advantage for patients accepting the offer of a circulatory death liver transplant. J Hepatol. 2019; 70: 855-865.
Hessheimer AJ, Coll E, Torres F,. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation. J Hepatol. 2019; 70: 658-665.
Pitarch Martínez M, Sánchez Pérez B, León Diáz FJ,. Donation after cardiac death in liver transplantation: an additional source of organs with similar results to donation after brain death. Transplant Proc. 2019; 51: 4-8.
Cascales-Campos PA, Ferreras D, Alconchel F,. Controlled donation after circulatory death up to 80 years for liver transplantation: pushing the limit again. Am J Transplant. 2020; 20: 204-212.
Otero A, Vázquez MA, Suárez F,. Results in liver transplantation using grafts from donors after controlled circulatory death: a single-center experience comparing donor grafts harvested after controlled circulatory death to those harvested after brain death. Clin Transplant. 2020; 34: e13763.
Jorgensen JE, Waljee AK, Volk ML,. Is MRCP equivalent to ERCP for diagnosing biliary obstruction in orthotopic liver transplant recipients? A meta-analysis. Gastrointest Endosc. 2011; 73: 955-962.
Xu YB, Min ZG, Jiang HX,. Diagnostic value of magnetic resonance cholangiopancreatography for biliary complications in orthotopic liver transplantation: a meta-analysis. Transplant Proc. 2013; 45: 2341-2346.
Boraschi P, Donati F,. Postoperative biliary adverse events following orthotopic liver transplantation: assessment with magnetic resonance cholangiography. World J Gastroenterol. 2014; 20: 11080-11094.
Fondevila C, Hessheimer AJ, Ruiz A,. Liver transplant using donors after unexpected cardiac death: novel preservation protocol and acceptance criteria. Am J Transplant. 2007; 7: 1849-1855.
Hessheimer AJ, Garciá-Valdecasas JC, Fondevila C,. Abdominal regional in-situ perfusion in donation after circulatory determination of death donors. Curr Opin Organ Transplant. 2016; 21: 322-328.
Lomero M, Gardiner D, Coll E, European Committee on Organ Transplantation of the Council of Europe (CD-P-TO). Donation after circulatory death today: an updated overview of the European landscape. Transpl Int. 2020; 33: 76-88.
Ruiz P, Gastaca M, Bustamante FJ,. Favorable outcomes after liver transplantation with normothermic regional perfusion from donors after circulatory death: a single-center experience. Transplantation. 2019; 103: 938-943.
Watson CJE, Hunt F, Messer S,. In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival. Am J Transplant. 2019; 19: 1745-1758.
Rojas-Peña A, Sall LE, Gravel MT,. Donation after circulatory determination of death: the University of Michigan experience with extracorporeal support. Transplantation. 2014; 98: 328-334.
Olivieri T, Magistri P, Guidetti C,. University of Modena experience with liver grafts from donation after circulatory death: what really matters in organ selection? Transplant Proc. 2019; 51: 2967-2970.
Hagness M, Foss S, Sørensen DW,. Liver transplant after normothermic regional perfusion from controlled donors after circulatory death: the Norwegian experience. Transplant Proc. 2019; 51: 475-478.
Foss S, Nordheim E, Sørensen DW,. First Scandinavian protocol for controlled donation after circulatory death using normothermic regional perfusion. Transplant Direct. 2018; 4: e366.
Miñambres E, Suberviola B, Dominguez-Gil B,. Improving the outcomes of organs obtained from controlled donation after circulatory death donors using abdominal normothermic regional perfusion. Am J Transplant. 2017; 17: 2165-2172.
Miñambres E, Ruiz P, Ballesteros MA,. Combined lung and liver procurement in controlled donation after circulatory death using normothermic abdominal perfusion. Initial experience in two Spanish centers. Am J Transplant. 2020; 20: 231-240.
Oniscu GC, Randle LV, Muiesan P,. In situ normothermic regional perfusion for controlled donation after circulatory death-the United Kingdom experience. Am J Transplant. 2014; 14: 2846-2854.
Rodríguez-Sanjuán JC, Ruiz N, Miñambres E,. Liver transplant from controlled cardiac death donors using normothermic regional perfusion: comparison with liver transplants from brain dead donors. Transplant Proc. 2019; 51: 12-19.
De Carlis R, Di Sandro S, Lauterio A,. Liver grafts from donors after circulatory death on regional perfusion with extended warm ischemia compared with donors after brain death. Liver Transpl. 2018; 24: 1523-1535.
Dondossola D, Lonati C, Zanella A,. Preliminary experience with hypothermic oxygenated machine perfusion in an Italian liver transplant center. Transplant Proc. 2019; 51: 111-116.
Hong JC, Yersiz H, Kositamongkol P,. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg. 2011; 146: 1017-1023.
Khorsandi SE, Giorgakis E, Vilca-Melendez H,. Developing a donation after cardiac death risk index for adult and pediatric liver transplantation. World J Transplant. 2017; 7: 203-212.
Schlegel A, Kalisvaart M, Scalera I,. The UK DCD Risk Score: a new proposal to define futility in donation-after-circulatory-death liver transplantation. J Hepatol. 2018; 68: 456-464.
van Rijn R, Schurink IJ, de Vries Y,. Hypothermic machine perfusion in liver transplantation-a randomized trial. N Engl J Med. 2021; 384: 1391-1401.